Michael Drebot
Overview
Explore the profile of Michael Drebot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
2197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emeterio K, Audet J, Zhu W, Leung A, Schulz H, He S, et al.
Heliyon
. 2025 Feb;
11(3):e42322.
PMID: 39968149
Orthoebolaviruses are non-segmented, negative sense RNA viruses that make up the genus in the family . Sudan virus (SUDV) is a highly pathogenic orthoebolavirus that causes severe disease in humans....
2.
Todoric D, Vrbova L, Mitri M, Gasmi S, Stewart A, Connors S, et al.
Can Commun Dis Rep
. 2023 Jun;
48(5):181-187.
PMID: 37325258
National West Nile virus (WNV) surveillance was established in partnership with the federal, provincial and territorial governments starting in 2000, with the aim to monitor the emergence and subsequent spread...
3.
Cholette F, Fabia R, Harris A, Ellis H, Cachero K, Schroeder L, et al.
Heliyon
. 2022 Sep;
8(9):e10270.
PMID: 36060461
The extent of the COVID-19 pandemic will be better understood through serosurveys and SARS-CoV-2 antibody testing. Dried blood spot (DBS) samples will play a central role in large scale serosurveillance...
4.
Valcourt E, Manguiat K, Robinson A, Lin Y, Abe K, Mubarek S, et al.
Microbiol Spectr
. 2022 Jun;
10(4):e0055322.
PMID: 35730975
No abstract available.
5.
Cholette F, Mesa C, Harris A, Ellis H, Cachero K, Lacap P, et al.
PLoS One
. 2021 Dec;
16(12):e0261003.
PMID: 34874948
The true severity of infection due to COVID-19 is under-represented because it is based on only those who are tested. Although nucleic acid amplifications tests (NAAT) are the gold standard...
6.
Valcourt E, Manguiat K, Robinson A, Lin Y, Abe K, Mubareka S, et al.
Microbiol Spectr
. 2021 Nov;
9(3):e0088621.
PMID: 34787495
The evaluation of humoral protective immunity against SARS-CoV-2 remains crucial in understanding both natural immunity and protective immunity conferred by the several vaccines implemented in the fight against COVID-19. The...
7.
Stein D, Osiowy C, Gretchen A, Thorlacius L, Fudge D, Lang A, et al.
Diagn Microbiol Infect Dis
. 2021 Aug;
101(3):115412.
PMID: 34425450
The COVID-19 pandemic has led to the influx of immunoassays for the detection of antibodies towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the global market. The Canadian Public...
8.
Griffin B, Chan M, Tailor N, Mendoza E, Leung A, Warner B, et al.
Nat Commun
. 2021 Jun;
12(1):3612.
PMID: 34127676
Widespread circulation of SARS-CoV-2 in humans raises the theoretical risk of reverse zoonosis events with wildlife, reintroductions of SARS-CoV-2 into permissive nondomesticated animals. Here we report that North American deer...
9.
Charlton C, Kanji J, Tran V, Kus J, Gubbay J, Osiowy C, et al.
Can Commun Dis Rep
. 2021 May;
47(4):171-183.
PMID: 34035663
The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic testing is rapidly evolving. While serology testing has limited diagnostic capacity for acute infection, its role in providing population-based...
10.
Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Wood H, et al.
Transfusion
. 2021 Mar;
61(5):1440-1446.
PMID: 33734448
Background: Convalescent plasma products are a potential passive immunotherapy for Coronavirus disease 2019 (COVID-19) disease. Various approaches have been utilized to determine the concentration of Severe acute respiratory syndrome coronavirus-2...